These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 31587352)

  • 1. Outcomes of splanchnic vein thrombosis in patients with myeloproliferative neoplasms in a single center experience.
    Tremblay D; Vogel AS; Moshier E; Hoffman R; Kremyanskaya M; Zhou S; Schiano T; Mascarenhas J
    Eur J Haematol; 2020 Jan; 104(1):72-73. PubMed ID: 31587352
    [No Abstract]   [Full Text] [Related]  

  • 2. Splanchnic vein thrombosis in patients with myeloproliferative neoplasms: The Mayo clinic experience with 84 consecutive cases.
    Lavu S; Szuber N; Mudireddy M; Yogarajah M; Gangat N; Pardanani A; Hanson CA; Ketterling RP; Ashrani AA; Kamath PS; Tefferi A
    Am J Hematol; 2018 Mar; 93(3):E61-E64. PubMed ID: 29194707
    [No Abstract]   [Full Text] [Related]  

  • 3. Survival in patients with familial and sporadic myeloproliferative neoplasms.
    Hultcrantz M; Lund SH; Landgren O; Samuelsson J; Goldin LR; Oddsson A; Björkholm M; Kristinsson SY
    Blood; 2015 Jun; 125(23):3665-6. PubMed ID: 26045595
    [No Abstract]   [Full Text] [Related]  

  • 4. Venetoclax plus hypomethylating agent in blast-phase myeloproliferative neoplasm: preliminary experience with 12 patients.
    Gangat N; Morsia E; Foran JM; Palmer JM; Elliott MA; Tefferi A
    Br J Haematol; 2020 Dec; 191(5):e120-e124. PubMed ID: 32945528
    [No Abstract]   [Full Text] [Related]  

  • 5. Splanchnic venous thrombosis driven by a constitutively activated JAK2 V617F philadelphia-negative myeloproliferative neoplasm: a case report.
    Waiswa M; Seremba E; Ocama P; Ddungu H; Opio K; Okello C; O'shea T; Verhovsek M; Mutyabule R
    Afr Health Sci; 2014 Dec; 14(4):1069-73. PubMed ID: 25834519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinct clinical, laboratory and molecular features of myeloproliferative neoplasm patients with splanchnic vein thrombosis.
    How J; Trinkaus KM; Oh ST
    Br J Haematol; 2018 Oct; 183(2):310-313. PubMed ID: 29048104
    [No Abstract]   [Full Text] [Related]  

  • 7. Heterogeneity among splanchnic vein thrombosis associated with myeloproliferative neoplasms.
    Cattaneo D; Gianelli U; Bianchi P; Cortelezzi A; Iurlo A
    Eur J Intern Med; 2018 Jun; 52():e25-e26. PubMed ID: 29567096
    [No Abstract]   [Full Text] [Related]  

  • 8. Splanchnic Vein Thrombosis in the Myeloproliferative Neoplasms.
    Akpan IJ; Stein BL
    Curr Hematol Malig Rep; 2018 Jun; 13(3):183-190. PubMed ID: 29644531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathological characterisation of myeloproliferative neoplasm-unclassifiable (MPN-U): a retrospective analysis from a large UK tertiary referral centre.
    Deschamps P; Moonim M; Radia D; Curto-Garcia N; Woodley C; Bassiony S; O'Sullivan J; Harrington P; Raj K; Francis Y; Kordasti S; Ali S; Harrison CN; McLornan DP
    Br J Haematol; 2021 May; 193(4):792-797. PubMed ID: 33751548
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Splanchnic vein thrombosis in acute pancreatitis: a single-center experience.
    Harris S; Nadkarni NA; Naina HV; Vege SS
    Pancreas; 2013 Nov; 42(8):1251-4. PubMed ID: 24152951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The JAK2 V617F Allele Burden in Latent Myeloproliferative Neoplasms Presenting with Splanchnic Vein Thrombosis.
    Goodyer M; Langabeer SE; Haslam K; Murphy K
    Pathol Oncol Res; 2016 Jan; 22(1):229-30. PubMed ID: 26450123
    [No Abstract]   [Full Text] [Related]  

  • 12. [Any splanchnic vein thrombosis must make look for a forme fruste of myeloproliferative disorder].
    Casadevall N; Valla D
    Rev Prat; 2005 Oct; 55(15):1669-70. PubMed ID: 16334203
    [No Abstract]   [Full Text] [Related]  

  • 13. Absence of JAK2V617F mutation in Chinese deep vein thrombosis patients without myeloproliferative neoplasms.
    Dong B; Zhang Y; Fu X; Wang G
    Thromb Res; 2012 May; 129(5):664-5. PubMed ID: 22197451
    [No Abstract]   [Full Text] [Related]  

  • 14. Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
    Galtier J; Drevon L; Le Bris Y; Giraudier S; Wemeau M; Legros L; Paz DL; Girodon F; Kiladjian JJ; Mesguich C; Parrens M; Mediavilla C; Roy L; Guy A; Mansier O; Ianotto JC; James C
    Haematologica; 2024 Jun; 109(6):1989-1993. PubMed ID: 38328854
    [No Abstract]   [Full Text] [Related]  

  • 15. Discrepancies between bone marrow histopathology and clinical phenotype in BCR-ABL1-negative myeloproliferative neoplasms associated with splanchnic vein thrombosis.
    Gianelli U; Iurlo A; Cattaneo D; Bossi A; Cortinovis I; Augello C; Moro A; Savi F; Castelli R; Brambilla C; Bianchi P; Primignani M; Cortelezzi A; Bosari S
    Leuk Res; 2015 May; 39(5):525-9. PubMed ID: 25840747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of thrombophilia in splanchnic vein thrombosis.
    Primignani M; Mannucci PM
    Semin Liver Dis; 2008 Aug; 28(3):293-301. PubMed ID: 18814082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cerebral vein thrombosis in patients with Philadelphia-negative myeloproliferative neoplasms. An European Leukemia Net study.
    Martinelli I; De Stefano V; Carobbio A; Randi ML; Santarossa C; Rambaldi A; Finazzi MC; Cervantes F; Arellano-Rodrigo E; Rupoli S; Canafoglia L; Tieghi A; Facchini L; Betti S; Vannucchi AM; Pieri L; Cacciola R; Cacciola E; Cortelezzi A; Iurlo A; Pogliani EM; Elli EM; Spadea A; Barbui T
    Am J Hematol; 2014 Nov; 89(11):E200-5. PubMed ID: 25042466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Splanchnic vein thromboses associated with myeloproliferative neoplasms: An international, retrospective study on 518 cases.
    Sant'Antonio E; Guglielmelli P; Pieri L; Primignani M; Randi ML; Santarossa C; Rumi E; Cervantes F; Delaini F; Carobbio A; Betti S; Rossi E; Lavi N; Harrison CN; Curto-Garcia N; Gisslinger H; Gisslinger B; Specchia G; Ricco A; Vianelli N; Polverelli N; Koren-Michowitz M; Ruggeri M; Girodon F; Ellis M; Iurlo A; Mannelli F; Mannelli L; Sordi B; Loscocco GG; Cazzola M; De Stefano V; Barbui T; Tefferi A; Vannucchi AM
    Am J Hematol; 2020 Feb; 95(2):156-166. PubMed ID: 31721282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Splanchnic vein thrombosis in myeloproliferative neoplasms.
    Sekhar M; McVinnie K; Burroughs AK
    Br J Haematol; 2013 Sep; 162(6):730-47. PubMed ID: 23855810
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thrombophilic genotypes, natural anticoagulants, and plasma homocysteine in myeloproliferative disorders: relationship with splanchnic vein thrombosis and arterial disease.
    Amitrano L; Guardascione MA; Ames PR; Margaglione M; Antinolfi I; Iannaccone L; Annunziata M; Ferrara F; Brancaccio V; Balzano A
    Am J Hematol; 2003 Feb; 72(2):75-81. PubMed ID: 12555209
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.